000788 北大医药
已收盘 05-15 15:00:00
资讯
新帖
简况
5月11日北大医药发布公告,股东减持164.07万股
证券之星 · 05-11
5月11日北大医药发布公告,股东减持164.07万股
北大医药(000788)披露获得《化学原料药上市申请批准通知书》,5月8日股价上涨1.31%
证券之星 · 05-08
北大医药(000788)披露获得《化学原料药上市申请批准通知书》,5月8日股价上涨1.31%
北大医药最新公告:获得枸橼酸托法替布化学原料药上市批准
证券之星 · 05-07
北大医药最新公告:获得枸橼酸托法替布化学原料药上市批准
北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,5月6日股价上涨0.65%
证券之星 · 05-06
北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,5月6日股价上涨0.65%
每周股票复盘:北大医药(000788)一季报营收降57.17%
证券之星 · 05-03
每周股票复盘:北大医药(000788)一季报营收降57.17%
北大医药(000788)3月31日股东户数5.6万户,较上期减少2.59%
证券之星 · 04-28
北大医药(000788)3月31日股东户数5.6万户,较上期减少2.59%
4月15日北大医药(000788)涨停分析:原料药获批、仿制药增长驱动
证券之星 · 04-15
4月15日北大医药(000788)涨停分析:原料药获批、仿制药增长驱动
国办一纸文件定调药价,创新药爆发!涨停名单还在拉长
格隆汇 · 04-15
国办一纸文件定调药价,创新药爆发!涨停名单还在拉长
北大医药:北大医疗减持落地1/4,持股降至10%
E药资本界 · 04-14
北大医药:北大医疗减持落地1/4,持股降至10%
股市必读:北大医药(000788)4月10日收盘跌5.93%,主力净流出183.62万元
证券之星 · 04-13
股市必读:北大医药(000788)4月10日收盘跌5.93%,主力净流出183.62万元
北大医药(000788)披露股票交易异常波动公告,4月3日股价下跌1.25%
中金财经 · 04-03
北大医药(000788)披露股票交易异常波动公告,4月3日股价下跌1.25%
2连板北大医药:公司不存在创新药业务
证券之星 · 04-02
2连板北大医药:公司不存在创新药业务
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
格隆汇 · 04-02
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
异动快报:北大医药(000788)4月2日9点50分触及涨停板
证券之星 · 04-02
异动快报:北大医药(000788)4月2日9点50分触及涨停板
股市必读:北大医药(000788)3月23日收盘跌6.29%,主力净流出342.54万元
证券之星 · 03-24
股市必读:北大医药(000788)3月23日收盘跌6.29%,主力净流出342.54万元
北大医药(000788)披露帕利哌酮原料药获准上市公告,3月17日股价下跌1.16%
证券之星 · 03-17
北大医药(000788)披露帕利哌酮原料药获准上市公告,3月17日股价下跌1.16%
北大医药(000788.SZ)帕利哌酮化学原料药上市申请获批准
智通财经 · 03-17
北大医药(000788.SZ)帕利哌酮化学原料药上市申请获批准
北大医药(000788)披露高级管理人员离任公告,3月12日股价下跌0.49%
证券之星 · 03-12
北大医药(000788)披露高级管理人员离任公告,3月12日股价下跌0.49%
北大医药最新公告:副总裁陈祥洪因个人原因辞职
证券之星 · 03-12
北大医药最新公告:副总裁陈祥洪因个人原因辞职
北大医药(000788)披露2025年前三季度权益分派实施公告,3月2日股价下跌3.5%
证券之星 · 03-02
北大医药(000788)披露2025年前三季度权益分派实施公告,3月2日股价下跌3.5%
加载更多
公司概况
公司名称:
北大医药股份有限公司
所属行业:
医药制造业
上市日期:
1997-06-16
主营业务:
北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、塞来昔布胶囊、右酮洛芬片、右酮洛芬胶囊、盐酸丁螺环酮片、奥氮平片。公司国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。
发行价格:
5.70
{"stockData":{"symbol":"000788","market":"SZ","secType":"STK","nameCN":"北大医药","latestPrice":5.67,"timestamp":1778828631000,"preClose":5.81,"halted":0,"volume":24027702,"delay":0,"changeRate":-0.0241,"floatShares":596000000,"shares":596000000,"eps":0.1078,"marketStatus":"已收盘","change":-0.14,"latestTime":"05-15 15:00:00","open":5.77,"high":5.78,"low":5.63,"amount":137000000,"amplitude":0.0258,"askPrice":5.68,"askSize":1575,"bidPrice":5.67,"bidSize":190,"shortable":0,"etf":0,"ttmEps":0.1078,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.81,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":6.39,"lowLimit":5.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":595987425,"isCdr":false,"pbRate":2.33,"roa":"--","peRate":52.597403,"roe":"2.17%","epsLYR":0.1391,"committee":0.22404,"marketValue":3379000000,"turnoverRate":0.0403,"status":1,"floatMarketCap":3379000000},"requestUrl":"/m/hq/s/000788/","defaultTab":"news","newsList":[{"id":"2634440752","title":"5月11日北大医药发布公告,股东减持164.07万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634440752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634440752?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:01","pubTimestamp":1778493691,"startTime":"0","endTime":"0","summary":"证券之星消息,5月11日北大医药发布公告《北大医药:关于持股5%以上股东减持计划时间届满暨减持股份实施情况的公告》,其股东北大医疗管理有限责任公司于2026年4月11日至2026年5月6日间合计减持164.07万股,占公司目前总股本的0.2753%,变动期间该股股价下跌2.84%,截止5月6日收盘报6.16元。股东增减持详情见下表:根据北大医药2026年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100025449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000788","BK0239","BK0102","BK0122","BK0028","BK0012","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431261","title":"北大医药(000788)披露获得《化学原料药上市申请批准通知书》,5月8日股价上涨1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633431261?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:49","pubTimestamp":1778233785,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,北大医药报收于6.2元,较前一交易日上涨1.31%,最新总市值为36.95亿元。该股当日开盘6.15元,最高6.22元,最低6.13元,成交额达1.54亿元,换手率为4.19%。北大医药于近日披露《关于获得〈化学原料药上市申请批准通知书〉的公告》。公告显示,公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》,批准公司生产的枸橼酸托法替布原料药注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800032130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0060","BK0028","BK0239","BK0012","BK0102","BK0096","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144268","title":"北大医药最新公告:获得枸橼酸托法替布化学原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144268","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633144268?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:09","pubTimestamp":1778155776,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》,药品通用名称为枸橼酸托法替布。该原料药获批将有利于公司推进“原料制剂一体化”战略,提升生产成本控制和供应链稳定性,对公司未来业绩有积极作用。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700037695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0239","BK0060","BK0096","000788","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633866591","title":"北大医药(000788)披露持股5%以上股东部分股份被司法处置的预披露公告,5月6日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633866591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633866591?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:08","pubTimestamp":1778062127,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘,北大医药报收于6.16元,较前一交易日上涨0.65%,最新总市值为36.71亿元。该股当日开盘6.12元,最高6.2元,最低6.03元,成交额达1.62亿元,换手率为4.44%。近日,北大医药发布《关于持股5%以上股东部分股份被司法处置的预披露公告》。本次拟被动减持股份5,959,800股,占公司总股本不足1%,通过集中竞价方式在2026年5月7日至8月4日期间实施。西南合成目前持股132,455,475股,占公司总股本22.22%。公司将持续关注进展并履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0060","BK0096","BK0102","BK0122","BK0012","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632674082","title":"每周股票复盘:北大医药(000788)一季报营收降57.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632674082","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632674082?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:42","pubTimestamp":1777750932,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,北大医药报收于6.12元,较上周的6.36元下跌3.77%。本周,北大医药4月28日盘中最高价报6.48元。业绩披露要点财务报告北大医药2026年一季报显示,一季度主营收入2.15亿元,同比下降57.17%;归母净利润2699.63万元,同比下降40.85%;扣非净利润2649.55万元,同比下降39.76%。公司公告汇总2025年年度报告摘要北大医药2025年年度报告摘要显示,2025年末总资产为1,992,815,885.46元,较上年末下降13.00%;归属于上市公司股东的净资产为1,561,878,794.97元,同比增长3.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630374486","title":"北大医药(000788)3月31日股东户数5.6万户,较上期减少2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630374486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630374486?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:43","pubTimestamp":1777369405,"startTime":"0","endTime":"0","summary":"证券之星消息,近日北大医药披露,截至2026年3月31日公司股东户数为5.6万户,较12月31日减少1491.0户,减幅为2.59%。在化学制药行业个股中,北大医药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.57万户。从股价来看,2025年12月31日至2026年3月31日,北大医药区间涨幅为0.25%,在此期间股东户数减少1491.0户,减幅为2.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800052327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0122","000788","BK0239","BK0096","BK0102","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627052409","title":"4月15日北大医药(000788)涨停分析:原料药获批、仿制药增长驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2627052409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627052409?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:33","pubTimestamp":1776238431,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药4月15日涨停收盘,收盘价6.77元。今日北大医药涨停的可能因素有:国家药监局批准其帕利哌酮原料药上市,夯实原料制剂一体化战略基础;核心仿制药业务同比增长30%,展现主业韧性;2026年第一次临时股东大会高票通过利润分配预案,彰显股东信心;银行授信融资计划获批,为业务拓展提供资金保障;叠加当日创新药与化学制药板块集体走强的行业催化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500022630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000788","BK0060","BK0028","BK0096","BK0012","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627405121","title":"国办一纸文件定调药价,创新药爆发!涨停名单还在拉长","url":"https://stock-news.laohu8.com/highlight/detail?id=2627405121","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627405121?lang=zh_cn&edition=full","pubTime":"2026-04-15 14:33","pubTimestamp":1776234822,"startTime":"0","endTime":"0","summary":"政策组合拳出击","market":"us","thumbnail":"https://img3.gelonghui.com/a401d-f3f18d25-b1d2-4d82-b91d-544aa33cb569.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-f3f18d25-b1d2-4d82-b91d-544aa33cb569.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4422353","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0122","BK0132","02162","BK0185","600572","BK1583","002038","BK0197","600488","06978","LU0196878994.USD","BK0070","BK0077","BK0097","BK0102","BK0209","301408","BK0060","BK1587","159992","BK0028","600267","BK0239","06990","BK1574","BK1161","000919","000788","BK0250","BK0188","BK0012","BK0096","002589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627495136","title":"北大医药:北大医疗减持落地1/4,持股降至10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627495136","media":"E药资本界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627495136?lang=zh_cn&edition=full","pubTime":"2026-04-14 09:54","pubTimestamp":1776131640,"startTime":"0","endTime":"0","summary":"北大医药发布股东权益变动公告,持股10.72%的控股股东北大医疗自 2026 年 4 月 1 日至 10 日,通过集中竞价累计减持431.91 万股,持股比例降至10.00%,触及 5% 整数位门槛。核心减持要点减持计划:北大医疗计划在 2 月 11 日至 5 月 10 日期间,减持不超过 1787.96 万股,其中集中竞价不超 1%、大宗不超 2%。本次减持仅完成了计划总量的约 24%。权益变动:减持后持股比例从 10.72% 回落至 10%,虽仍为第一大股东,但持股比例进一步下降,需警惕后续持续减仓风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-14/doc-inhummyn4314081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000788","BK0102","159891","BK0096","BK0122","BK0239","BK0060","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627103749","title":"股市必读:北大医药(000788)4月10日收盘跌5.93%,主力净流出183.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627103749","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627103749?lang=zh_cn&edition=full","pubTime":"2026-04-13 01:12","pubTimestamp":1776013929,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,北大医药报收于6.34元,下跌5.93%,换手率17.37%,成交量103.5万手,成交额6.6亿元。交易信息汇总4月10日北大医药收盘报6.34元,跌5.93%,当日成交1.03亿元。根据收盘数据统计,该股近5个交易日中有2日跌幅超5%。前10个交易日资金流向情况:主力资金累计净流入7057.24万元,股价累计上涨10.8%;融资余额累计减少130.39万元,融券余量累计增加1500股。资金流向4月10日主力资金净流出183.62万元;游资资金净流出1518.34万元;散户资金净流入1701.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300000556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0239","BK0096","BK0028","BK0102","BK0122","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624289656","title":"北大医药(000788)披露股票交易异常波动公告,4月3日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624289656","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624289656?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:12","pubTimestamp":1775207522,"startTime":"0","endTime":"0","summary":"北大医药于近日披露《关于股票交易异常波动的公告》。公告显示,公司股票于2026年4月1日、4月2日连续两个交易日内收盘价格涨幅偏离值累计超过20%,构成股票交易异常波动。控股股东在异常波动期间无买卖公司股票行为,第二大股东处于已披露的减持计划实施阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32124839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0060","000788","BK0239","BK0102","BK0122","BK0028","BK0012","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624158577","title":"2连板北大医药:公司不存在创新药业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2624158577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624158577?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:40","pubTimestamp":1775122840,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)发布异动公告,经核查,截止本公告披露日,公司不存在创新药业务,主要从事化学药品制剂(仿制药制剂)的研发、生产和销售,主要产品涵盖“抗感染类、镇痛类、精神类、慢病类”等领域。截止本公告披露日,公司第二大股东北大医疗管理有限责任公司尚处于此前已披露的减持计划实施阶段,其减持期间为2026年2月11日至2026年5月10日。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200032325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","159992","BK0096","BK1161","06978","BK0012","BK0060","000788","BK0122","BK1574","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"hk","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["UGL","159934","GCmain","GLD","PHYS","000788","06978","JDST","AAAU","DGP","02186","BK4585","USG","DUST","603222","BTGD","300086","518880","1OZmain","SGOL","159831","GDXD","GLL","NUGT","GLTR","GDXU","QOmain","CEF","GDXJ","OUNZ","000950","02162","GDXY","SGCmain","IAUI","DZZ","JNUG","600594","600488","BK0188","159992","GDX","GLDM","BK1191","XME","SGUmain","IAUM","PALL","MGCmain","IAU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624252624","title":"异动快报:北大医药(000788)4月2日9点50分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2624252624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624252624?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:50","pubTimestamp":1775094642,"startTime":"0","endTime":"0","summary":"证券之星4月2日盘中消息,9点50分北大医药(000788)触及涨停板。其所属行业化学制药目前下跌。领涨股为津药药业。该股为医药商业,高校系,医药概念热股,当日医药商业概念上涨0.78%,高校系概念上涨0.35%。4月1日的资金流向数据方面,主力资金净流入1.54亿元,占总成交额36.45%,游资资金净流出5979.02万元,占总成交额14.15%,散户资金净流出9418.07万元,占总成交额22.29%。近5日资金流向一览见下表:北大医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200008514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0096","BK0060","000788","BK0102","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621081642","title":"股市必读:北大医药(000788)3月23日收盘跌6.29%,主力净流出342.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621081642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621081642?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:53","pubTimestamp":1774295588,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,北大医药报收于5.36元,下跌6.29%,换手率2.67%,成交量15.94万手,成交额8718.4万元。交易信息汇总股价提醒3月23日北大医药收盘报5.36元,跌6.29%,当日成交1593.72万元。该股已连续3日下跌。前10个交易日中,主力资金累计净流出6458.6万元,股价累计下跌12.26%;融资余额累计减少130.39万元,融券余量累计增加1500股。资金流向3月23日主力资金净流出342.54万元,游资资金净流出92.69万元,散户资金净流入435.23万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","000788","BK0239","BK0060","BK0102","BK0012","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620473464","title":"北大医药(000788)披露帕利哌酮原料药获准上市公告,3月17日股价下跌1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473464","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473464?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:22","pubTimestamp":1773757342,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘,北大医药报收于5.99元,较前一交易日下跌1.16%,最新总市值为35.7亿元。该股当日开盘6.06元,最高6.14元,最低5.98元,成交额达7166.16万元,换手率为1.98%。近日,北大医药股份有限公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》,帕利哌酮原料药获准上市。帕利哌酮是利培酮的主要活性代谢产物,为第二代抗精神病药物,适用于成人及12-17岁青少年精神分裂症的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0060","000788","BK0122","BK0239","BK0028","BK0096","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262447","title":"北大医药(000788.SZ)帕利哌酮化学原料药上市申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262447","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620262447?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:04","pubTimestamp":1773738274,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)公告,公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》。相关原料药为帕利哌酮,是利培酮的主要活性代谢产物,属于第二代抗精神病药物,控制作用强,亲和力、耐受性及药效均较高,主要适用于成人及12-17岁青少年(体重≥29Kg)精神分裂症的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"北大医药(000788.SZ)帕利哌酮化学原料药上市申请获批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0060","BK0102","BK0028","BK0239","000788","BK0122","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618130488","title":"北大医药(000788)披露高级管理人员离任公告,3月12日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618130488","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618130488?lang=zh_cn&edition=full","pubTime":"2026-03-12 22:32","pubTimestamp":1773325941,"startTime":"0","endTime":"0","summary":"截至2026年3月12日收盘,北大医药报收于6.1元,较前一交易日下跌0.49%,最新总市值为36.36亿元。该股当日开盘6.13元,最高6.14元,最低6.07元,成交额达5382.83万元,换手率为1.48%。北大医药股份有限公司近日披露《关于公司高级管理人员离任的公告》。陈祥洪先生原定任期为2024年6月27日至2027年6月26日,辞职报告自送达董事会之日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200038938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0122","BK0096","BK0102","BK0060","000788","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618618019","title":"北大医药最新公告:副总裁陈祥洪因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2618618019","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618618019?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:40","pubTimestamp":1773308409,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司董事会近日收到副总裁陈祥洪的书面辞职报告,陈祥洪因个人原因申请辞去公司副总裁职务,不再担任公司任何职务。陈祥洪原定任期为2024年6月27日至2027年6月26日。根据相关规定,陈祥洪的辞职不会影响公司生产经营工作的正常开展,其辞职报告自送达公司董事会之日起生效。陈祥洪未直接或间接持有公司股票,不存在应当履行而未履行的承诺事项。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200030972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","000788","BK0239","BK0060","BK0102","BK0012","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616359579","title":"北大医药(000788)披露2025年前三季度权益分派实施公告,3月2日股价下跌3.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616359579","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616359579?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:31","pubTimestamp":1772465471,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,北大医药报收于6.07元,较前一交易日下跌3.5%,最新总市值为36.18亿元。该股当日开盘6.22元,最高6.23元,最低6.03元,成交额达1.11亿元,换手率为3.05%。近日,北大医药股份有限公司发布《2025年前三季度权益分派实施公告》。公告显示,公司2025年前三季度权益分派方案已获2026年第一次临时股东会审议通过。本次分配不送红股,不以资本公积金转增股本。现金红利由中国结算深圳分公司代派,部分股东由公司自行派发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","BK0012","BK0102","BK0122","000788","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779022508575,"stockEarnings":[{"period":"1week","weight":-0.0855},{"period":"1month","weight":-0.1625},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.1332},{"period":"1year","weight":0.0317},{"period":"ytd","weight":-0.0466}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北大医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"56011人(较上一季度减少2.59%)","perCapita":"10640股","listingDate":"1997-06-16","address":"重庆市北碚区水土镇方正大道21号","registeredCapital":"59598万元","survey":" 北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、塞来昔布胶囊、右酮洛芬片、右酮洛芬胶囊、盐酸丁螺环酮片、奥氮平片。公司国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。","listedPrice":5.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北大医药,000788,北大医药股票,北大医药股票老虎,北大医药股票老虎国际,北大医药行情,北大医药股票行情,北大医药股价,北大医药股市,北大医药股票价格,北大医药股票交易,北大医药股票购买,北大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}